When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a means to detect the presence of cancer by detecting these cancer cells floating in blood samples. However, current state-of-the-art methods have necessitated trained specialists to comb through and review images of thousands
By focusing on a trigger of brain inflammation, scientists are in pursuit of a new drug therapy and now understand why some with a key risk factor for the disease develop dementia. Backed by the combined expertise of three USC schools, scientists are developing a new drug aimed at a previously unexplored biological target in
Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer’s disease by measuring proteins linked to the condition. The new test, known as Penta-Plex Alzheimer’s Disease Capture Sandwich Immunoassay (5ADCSI), detects five biomarkers simultaneously, which is more than existing blood tests, and runs on
Today, a USC-licensed startup that developed an intranasal drug delivery system for brain tumors will be listed for the first time on Nasdaq. To celebrate the direct listing, the USC Stevens Center for Innovation and the startup, NeOnc Technologies Holdings Inc., will ring the opening bell at 9:30 a.m. EDT/6:30 a.m. PDT. NeOnc is based
In pediatric cardiology, every heartbeat counts, especially for the one in 4,000 newborns born with an underdeveloped lower chamber, or ventricle, of the heart. Ellis Meng, the Shelly and Ofer Nemirovsky Chair in Convergent Bioscience and professor of biomedical engineering and electrical and computer engineering, and her team are leading innovative research aimed at enhancing survival
USC scientists and Paula Cannon, a Distinguished Professor of Molecular Microbiology & Immunology at the Keck School of Medicine of USC, have discovered a way to turn the body’s B cells into tiny surveillance machines and antibody factories that can pump out specially designed antibodies to destroy cancer cells or HIV, two of medicine’s most
Congratulations to Dr. Valter Longo, Director of the Longevity Institute at USC and his venture, L-Nutra Inc., a premier nutri-technology company leading longevity science nutrition programs, on the closure of a $47M Series D funding. The round was led by a personal investment from Stephane Bancel, CEO at Moderna Inc., alongside Brentwood Associates, a Los Angeles based middle
Behavioral Signals, a startup company based on the research of USC Professor Shrikanth “Shri” Narayanan, received a 2020 Hacker Noon Noonies Award for “Innovative Company of the Year: Artificial Intelligence Technology.”
Microscape and Optimal IC Technologies, two startups with roots at the University of Southern California, have been selected to present at the First Look SoCal Showcase on Sept. 15-16, 2020.
The initial goal of the collaboration is to build low-income housing and disaster relief facilities. According to Contour Crafting, a 2,000-square-foot house can be 3D printed in a few days as opposed to a few weeks for just a fraction of the cost of traditional building techniques.
USC Stevens Center for Innovation - MC 0705
3720 S Flower Street Floor 3
Los Angeles, CA 90089
USC does not endorse or recommend any company, product, or service mentioned here. This information is not investment advice and should not be relied upon.